Learning Objectives:

1. Understand definition N2 disease in NSCLC

2.Understand significance of N2 disease in NSCLC

3. Summarize completed phase III trials leading to current treatment strategies

Session date: 
Friday, September 25, 2020 - 2:00pm to 3:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jori Sheade, MD